Phenylephrine Hydrochloride; Tropicamide Patent Expiration
Phenylephrine Hydrochloride; Tropicamide is used for dilating the pupils and reducing eye pressure. It was first introduced by Eyenovia Inc
Phenylephrine Hydrochloride; Tropicamide Patents
Given below is the list of patents protecting Phenylephrine Hydrochloride; Tropicamide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mydcombi | US10839960 | Ophthalmic drug delivery | Jul 15, 2031 | Eyenovia |
| Mydcombi | US11398306 | Ophthalmic drug delivery | Jul 15, 2031 | Eyenovia |
| Mydcombi | US11839487 | Ophthalmic drug delivery | Jul 15, 2031 | Eyenovia |
Phenylephrine Hydrochloride; Tropicamide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List